Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Argen-X | Brussels | Healthcare | Biotechnology & Medical Research | EUR 35.03B | 44.9x | -11.15 | EUR 576.20 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.2% Upside | Upgrade to Pro+ | |
Sequana Medical | Brussels | Healthcare | Biotechnology & Medical Research | EUR 76M | -1.6x | -0.09 | EUR 1.45 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Celyad | Brussels | Healthcare | Biotechnology & Medical Research | EUR 19.47M | -2.1x | -0.03 | EUR 0.47 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oxurion | Brussels | Healthcare | Biotechnology & Medical Research | EUR 709.48K | EUR 0.19 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |